However, it might possible that increased expression of PPARγ is not functionally important, as cerebral ischemia reduces the PPARγ-DNA binding, but treatment with PPARγ agonists such as 15-deoxy-PGJ2 or rosiglitazone recovers their functionality. Here, PPARG is linked to brain ischemia.